ClinicalTrials.Veeva

Menu

Action Observation and Motor Imagery Therapy in Stroke

K

Karamanoğlu Mehmetbey University

Status

Enrolling

Conditions

Stroke

Treatments

Other: Action observation and motor imagery therapy for rehabilitation
Other: Sham action observation and motor imagery therapy for rehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT06166862
09-2023/02

Details and patient eligibility

About

In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in stroke. Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Mirror neurons are activated during the performance of goal-directed actions, also when observing the same action and visualizing the action in the mind.

This clinical trial aims to test whether the application of AO and MI treatment in stroke in addition to conventional rehabilitation programs has an additional effect on motor recovery, activities of daily living, and quality of life.

Full description

Stroke is one of the most common neurological disorders that causes chronic disability in adulthood. Stroke-related neurological dysfunction causes impairment in motor and sensory skills and limitation in the ability to perform daily living activities, resulting in decreased independence of patients. This process causes significant impairment in the quality of life of stroke patients.

In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in stroke. Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Mirror neurons are activated during the performance of goal-directed actions, also when observing the same action and visualizing the action in the mind.

This clinical trial aims to test whether the application of AO and MI treatment in stroke in addition to conventional rehabilitation programs has an additional effect on motor recovery, activities of daily living, and quality of life.

Enrollment

56 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who had a stroke in the last year
  • Functional Ambulation Classification score 2-5

Exclusion criteria

  • Patients who have had repeated strokes
  • Patients with neglect
  • Patients with cognitive dysfunction (those who cannot follow simple verbal instructions)
  • Patients with severe hearing problems
  • Patients with severe vision problems
  • Patients with additional musculoskeletal system pathology that will affect physical performance (such as amputation, severe joint mobility limitation, peripheral nerve damage)
  • Patients with uncontrolled hypertension and diabetes mellitus
  • Patients with a history of symptomatic lung disease (such as asthma, chronic obstructive pulmonary disease, emphysema)
  • Patients with a history of symptomatic cardiac disease (such as coronary artery disease, arrhythmia, heart failure)
  • Patients with peripheral artery disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

56 participants in 2 patient groups

Action observation and motor imagery therapy for rehabilitation
Experimental group
Description:
Action observation and motor imagery therapy for rehabilitation in stroke patients in addition to conventional rehabilitation programs.
Treatment:
Other: Action observation and motor imagery therapy for rehabilitation
Sham action observation and motor imagery therapy for rehabilitation
Sham Comparator group
Description:
Sham comparator for action observation and motor imagery therapy for rehabilitation in stroke patients in addition to conventional rehabilitation programs.
Treatment:
Other: Sham action observation and motor imagery therapy for rehabilitation

Trial contacts and locations

1

Loading...

Central trial contact

Aynur Basaran, MD, Prof.; Yurdagul Bahran Mustu, MD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems